Showing results (121-130 of 196) with videos related to
Sort By:
Pageof 20
Cancer|January 22, 2013
Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005)Martee L Hensley, J Kyle Wathen, Robert G Maki, et al.The Journal of Urology|July 19, 2008
A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agentsNizar M Tannir, Peter F Thall, Chaan S Ng, et al.Cancer|January 28, 2003
Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinomaDanai D Daliani, Vasily Assikis, Shi-Ming Tu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancerArlene O Siefker-Radtke, Ashish M Kamat, H Barton Grossman, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2002
Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemiaBorje S Andersson, Peter F Thall, Timothy Madden, et al.Stroke|July 12, 2008
Practical model-based dose finding in early-phase clinical trials: optimizing tissue plasminogen activator dose for treatment of ischemic stroke in childrenHarry T Whelan, John D Cook, Catherine M Amlie-Lefond, et al.International Journal of Radiation Oncology, Biology, Physics|January 6, 2019
A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine GliomaMark J Amsbaugh, Anita Mahajan, Peter F Thall, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemiaPaul M Armistead, Marcos de Lima, Sherry Pierce, et al.Transplantation|October 27, 2009
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantationStefan O Ciurea, Marcos de Lima, Pedro Cano, et al.International Journal of Radiation Oncology, Biology, Physics|August 8, 2012
Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancerSteven H Lin, Lu Wang, Bevan Myles, et al.Pageof 20